Results of Meeting
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
20 NOVEMBER 2025
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
ABN: 57 647 877 889
Results of Annual General Meeting
Sydney, Australia – 20 November 2025 – Radiopharm Theranostics (ASX:RAD) advises that all resolutions
considered at the Annual General Meeting held today were carried by poll.
In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of
the proxies received and votes cast in respect of each resolution are attached.
As more than 75% of votes received were cast in favour of Resolution 1, Resolution 10 was withdrawn.
Further to the announcement on 19 November 2025 regarding the appointment of Mr Bruce Goodwin
as a Non-Executive Director, the Company confirms the re-appointment of Mr Bruce Goodwin as a Non-
Executive Director under section 201H(1) of the Corporations Act 2001 following the end of the Annual
General Meeting.
Phillip Hains
Joint Company Secretary
Disclosure of Proxy Votes
Radiopharm Theranostics Limited
Annual General Meeting
Thursday, 20 November 2025
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.
Automic
GPO Box 5193, Sydney, NSW 2001
P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world)
F +61 (0)2 8583 3040 E hello@automic.com.au
ABN 27 152 260 814
Proxy Votes
Poll Results (if
applicable)
Results
Resolution
Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
FOR AGAINST ABSTAIN
PROXY'S
DISCRETION
FOR AGAINST ABSTAIN OUTCOME
S250U
APPLICABLE
1 Remuneration Report P 1,084,096,640
911,862,142
84.11%
172,036,162
15.87%
29,396,870
198,336
0.02%
912,142,333
84.13%
172,036,162
15.87%
2 Re-election of Director – Mr Paul Hopper P 1,109,857,736
935,063,731
84.25%
174,695,669
15.74%
162,110,786
98,336
0.01%
935,243,922
84.26%
174,695,669
15.74%
162,110,786 Carried n/a
3 Re-election of Director – Ms Hester Larkin P 1,271,570,902
1,107,334,584
87.08%
164,037,982
12.90%
397,620
198,336
0.02%
1,107,614,775
87.10%
164,037,982
12.90%
397,620 Carried n/a
4 Ratification of prior issue of Placement Shares to
Lantheus
P 987,926,986
976,340,262
98.83%
11,488,388
1.16%
1,083,023
98,336
0.01%
976,520,453
98.84%
11,488,388
1.16%
1,083,023 Carried n/a
5 Approval to issue Equity Securities under
Omnibus Incentive Plan
P 1,084,572,755
904,596,999
83.41%
179,920,185
16.59%
187,395,767
55,571
0.01%
904,734,425
83.41%
179,920,185
16.59%
187,395,767 Carried n/a
6 Approval to issue Incentive Options to Director –
Mr Paul Hopper
P 1,084,862,909
904,454,681
83.37%
180,352,657
16.62%
93,534,185
55,571
0.01%
904,592,107
83.38%
180,352,657
16.62%
93,534,185 Carried n/a
7 Approval to issue Incentive Options to Director –
Mr Riccardo Canevari
P 1,084,862,909
1,012,916,596
93.37%
71,790,742
6.62%
187,105,613
155,571
0.01%
1,013,154,022
93.38%
71,790,742
6.62%
187,105,613 Carried n/a
8 Approval to issue Incentive Options to Director –
Mr Ian Turner
P 1,084,812,909
914,247,461
84.28%
170,409,877
15.71%
187,155,613
155,571
0.01%
914,484,887
84.29%
170,409,877
15.71%
187,155,613 Carried n/a
29,396,870 Carried No
Proxy Votes
Poll Results (if
applicable)
Results
Resolution
Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
FOR AGAINST ABSTAIN
PROXY'S
DISCRETION
FOR AGAINST ABSTAIN OUTCOME
S250U
APPLICABLE
9 Approval of 10% capacity under Listing Rule 7.1A P 1,228,497,414
1,160,228,155
94.44%
68,113,688
5.54%
43,471,108
155,571
0.01%
1,160,465,581
94.46%
68,113,688
5.54%
43,471,108 Carried n/a
10 Contingent business - Board Spill Meeting
(conditional item)
If less than 25% of the votes cast on Resolution 1
are voted against adoption of the Remuneration
Report, the Chair will withdraw Resolution 10.
IMPORTANT - The Board strongly recommends
you vote against Resolution 10.
- 1,112,253,075
264,532,620
23.78%
847,664,884
76.21%
1,240,435
55,571
0.00%
Resolution withdrawn - n/a
Share your feedback
Discover